Teva Pharmaceutical Industries Net Profit Margin 2010-2024 | TEVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Teva Pharmaceutical Industries average net profit margin for 2023 was -11.47%, a 28.59% decline from 2022.
Teva Pharmaceutical Industries average net profit margin for 2022 was -8.92%, a 13.65% increase from 2021.
Teva Pharmaceutical Industries average net profit margin for 2021 was -10.33%, a 21.98% decline from 2020.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Teva Pharmaceutical Industries average net profit margin for 2023 was -11.47%, a 28.59% decline from 2022.
Teva Pharmaceutical Industries average net profit margin for 2022 was -8.92%, a 13.65% increase from 2021.
Teva Pharmaceutical Industries average net profit margin for 2021 was -10.33%, a 21.98% decline from 2020.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Dr Reddy's Laboratories (RDY)	$13.1B
BridgeBio Pharma (BBIO)	$5B
Bausch Health Cos (BHC)	$3B
Amphastar Pharmaceuticals (AMPH)	$2.4B
Supernus Pharmaceuticals (SUPN)	$1.8B
Taysha Gene Therapies (TSHA)	$449M
Personalis (PSNL)	$315M
Assembly Biosciences (ASMB)	$117M
Acasti Pharma (ACST)	$28M
Sol-Gel Technologies (SLGL)	$20M
Evoke Pharma (EVOK)	$4M
Teligent (TLGT)	$0M